Sequential neoadjuvant chemoradiotherapy (CRT) followed by curative surgery vs. primary surgery alone for resectable, non-metastasized pancreatic adenocarcinoma: NEOPA- a randomized multicenter phase III study (NCT01900327, DRKS00003893, ISRCTN82191
about
Efficacy of Neo-Adjuvant Chemoradiotherapy for Resectable Pancreatic Adenocarcinoma: A PRISMA-Compliant Meta-Analysis and Systematic ReviewPancreatic cancer and liver metastases: state of the art.Neoadjuvant treatment for resectable pancreatic adenocarcinoma.Recent Advances in Pancreatic Cancer Surgery.CT imaging of early local recurrence of pancreatic adenocarcinoma following pancreaticoduodenectomy.The role of neoadjuvant therapy in pancreatic cancer: a review.Adjuvant and neoadjuvant therapies in resectable pancreatic cancer: a systematic review of randomized controlled trials.When, What, and Why of Perioperative Treatment of Potentially Curable Pancreatic Adenocarcinoma.Outcomes after extended pancreatectomy in patients with borderline resectable and locally advanced pancreatic cancer.Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinoma.Neoadjuvant Therapy of Pancreatic Cancer: Definitions and Benefits.Neoadjuvant therapy for pancreatic cancer: an ongoing debate.Neoadjuvant chemoradiation for non-metastatic pancreatic cancer increases margin-negative and node-negative rates at resection.Preoperative CT in patients with surgically resectable pancreatic adenocarcinoma: does the time interval between CT and surgery affect survival?Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer.
P2860
Q28079611-B0B99EB9-19B3-466A-8FF9-607D2C13F8B5Q30241486-FDC5B053-18D8-4591-B0E6-90061ACD5E0FQ36526141-304873A5-9CC6-4BB7-80A9-B3E0F48CE72EQ38602630-7DC93659-5F98-44CD-9AA0-4D9B74455F8BQ38729914-F123719E-8E67-43D5-89A6-2FCDEF2FA85DQ38734981-DFF815AC-6529-4373-A9D2-713880449D0CQ38736437-198BE8C5-D34D-410D-845B-DC3A82640B43Q39060622-764A6E42-BBC5-4E41-82D8-A16FCE1F884AQ39338280-5F23671D-384A-42FF-99AF-9EE908FFBE75Q41491695-91ECEE18-DFAB-4BF9-8130-9D40D6A18E65Q41573034-EA153B37-40B4-4D06-A458-CD290BAA1D8BQ41826893-AF4DFA93-AC29-4ACE-A26B-0AD72B03A3C8Q47750487-0B323A65-B065-4319-BDA9-A3108B78BE92Q50536698-F147897D-0966-412B-A363-0A3B529F90B3Q55634822-DC85C7C9-5AB3-4CD5-8AC9-946355458CDA
P2860
Sequential neoadjuvant chemoradiotherapy (CRT) followed by curative surgery vs. primary surgery alone for resectable, non-metastasized pancreatic adenocarcinoma: NEOPA- a randomized multicenter phase III study (NCT01900327, DRKS00003893, ISRCTN82191
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Sequential neoadjuvant chemora ...... 327, DRKS00003893, ISRCTN82191
@ast
Sequential neoadjuvant chemora ...... 327, DRKS00003893, ISRCTN82191
@en
type
label
Sequential neoadjuvant chemora ...... 327, DRKS00003893, ISRCTN82191
@ast
Sequential neoadjuvant chemora ...... 327, DRKS00003893, ISRCTN82191
@en
prefLabel
Sequential neoadjuvant chemora ...... 327, DRKS00003893, ISRCTN82191
@ast
Sequential neoadjuvant chemora ...... 327, DRKS00003893, ISRCTN82191
@en
P2093
P2860
P921
P356
P1433
P1476
Sequential neoadjuvant chemora ...... 327, DRKS00003893, ISRCTN82191
@en
P2093
Cordula Petersen
Emre Yekebas
Florian Gebauer
Jakob Robert Izbicki
Karl Wegscheider
Martin Trepel
Maximilian Bockhorn
Michael Tachezy
Phillipe Schafhausen
P2860
P2888
P356
10.1186/1471-2407-14-411
P407
P50
P577
2014-06-07T00:00:00Z
P5875
P6179
1037928658